Nature

Which patent and where? Why international patent transparency by companies is needed for medicines

A common method for determining the patent status of medicines internationally is highly imprecise and complicates medicine access by obscuring the true medicine patent landscape for policymakers and ...
JD Supra

To Patent Or Not To Patent? Preserving Trade Secret Status During Prosecution

Amid a growing body of unsettled law regarding the patentability of software and business methods patents, companies are increasingly choosing to maintain their valuable innovations as trade secrets ...
JD Supra

Determining Entity Status Before the United States and Patent Trademark Office: Large, Small, or Micro?

At the time of filing any patent application with the United States and Patent Trademark Office (USPTO), patent applicants must designate their entity status. Selecting the correct entity status can ...
Managingip.com

Design patent counsel keen to retain obviousness status quo

Design patent counsel are concerned that an upcoming case at the Court of Appeals for the Federal Circuit could result in uncertainty over when design patents are obvious. The Federal Circuit granted ...
IPWatchdog

Patent Pro Bono Program and Micro Entity Status

Recently, I interviewed Jennifer McDowell, Coordinator of the USPTO’s Patent Pro Bono Program. The Pro Bono Team at the USPTO are tasked with ensuring that the Patent Pro Bono Program is fully ...